$1.48
00.00%
Pre-Market: 8:49 AM EDT
15 minutes delayed
Comments
Loading...
Oncternal Therapeutics (ONCT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOncternal Therapeutics (NASDAQ:ONCT) Stock Quotes, Forecast and News Summary
Oncternal Therapeutics Stock (NASDAQ: ONCT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Oncternal Therapeutics (ONCT) stock?
You can purchase shares of Oncternal Therapeutics (NASDAQ:ONCT) through any online brokerage.
Who are Oncternal Therapeutics (ONCT) competitors?
Other companies in Oncternal Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Oncternal Therapeutics (ONCT) stock?
Oncternal Therapeutics has a consensus price target of $6.58.
What is the current price for Oncternal Therapeutics (ONCT)?
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $1.48 last updated September 24, 2024 at 8:49 AM EDT.
Does Oncternal Therapeutics (ONCT) pay a dividend?
There are no upcoming dividends for Oncternal Therapeutics.
When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?
Oncternal Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Oncternal Therapeutics (ONCT) going to split?
There is no upcoming split for Oncternal Therapeutics.
What sector and industry does Oncternal Therapeutics (ONCT) operate in?
Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.